Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study. Ueda P, Wintzell V, Melbye M, Eliasson B, et al. Diabetologia 2021;64:2204-2214.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ueda P, Wintzell V, Melbye M, Eliasson B, et al. Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study. Diabetologia 2021;64:2204-2214.
PMID: 34254177